Erythropoiesis after therapy with recombinant human erythropoietin: A dose-response study in anemic cancer surgery patients

Marco Braga,Luca Gianotti,Oreste Gentilini,A. Vignali,L. Corizia,V. Di Carlo

Vox Sanguinis（1999）

引用 0|浏览0

暂无评分

摘要

Background and Objectives: Preoperative treatment with 600 U/kg of recombinant human erythropoietin (r–HuEPO) effectively increases erythropoiesis in cancer patients. The aim of t

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要